Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | PDE4A | P27815 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL760207 | 0.90 | — | — | |
| SCHEMBL13062506 | 0.87 | — | — | |
| SCHEMBL4409027 | 0.87 | — | — | |
| SCHEMBL9564560 | 0.87 | — | — | |
| SCHEMBL283543 | 0.87 | — | — | |
| SCHEMBL4409028 | 0.87 | — | — | |
| SCHEMBL346604 | 0.87 | — | — | |
| SCHEMBL8927312 | 0.79 | THRB (0.43) | THRBLMNAL3MBTL1TDP1ALDH1A1 | |
| E968 SCHEMBL29094185 | 0.78 | THRB (0.65) | THRBLMNAL3MBTL1TDP1PDE4A | |
| Phosphoric Acid SCHEMBL27900335 | 0.77 | PTPN1 (0.35) | THRBTDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1982005-B1 | METHODS FOR THE ELECTROLYTIC PRODUCTION OF ERYTHROSE OR ERYTHRITOL | DYNAMIC FOOD INGREDIENTS CORP (US) | 2013-08-07 | — | — | EP | disclosed |
| US-20070181437-A1 | Methods for the electrolytic production of erythrose or erythritol | DFI USA, LLC | 2007-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070181437-A1 | Methods for the electrolytic production of erythrose or erythritol | ALDOA, DERA, AGL | THRB 2919/4885LMNA 2844/4885L3MBTL1 3949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.